InvestorsHub Logo
Followers 840
Posts 120476
Boards Moderated 18
Alias Born 09/05/2002

Re: DewDiligence post# 15620

Wednesday, 06/08/2016 11:28:11 AM

Wednesday, June 08, 2016 11:28:11 AM

Post# of 20689
Correction to #msg-123102901: The number of patients in the phase-2 portion of the Necuparanib trial is approximately 150 (not 180). Source: today’s GS webcast.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”